Literature DB >> 18524795

Multiple endocrine neoplasia type 1 in Brazil: MEN1 founding mutation, clinical features, and bone mineral density profile.

D M Lourenço1, R A Toledo, I I Mackowiak, F L Coutinho, M G Cavalcanti, J E M Correia-Deur, F Montenegro, S A C Siqueira, L C Margarido, M C Machado, S P A Toledo.   

Abstract

OBJECTIVE: Only few large families with multiple endocrine neoplasia type 1 (MEN1) have been documented. Here, we aimed to investigate the clinical features of a seven-generation Brazilian pedigree, which included 715 at-risk family members.
DESIGN: Genealogical and geographic analysis was used to identify the MEN1 pedigree. Clinical and genetic approach was applied to characterize the phenotypic and genotypic features of the family members.
RESULTS: Our genetic data indicated that a founding mutation in the MEN1 gene has occurred in this extended Brazilian family. Fifty family members were diagnosed with MEN1. Very high frequencies of functioning and non-functioning MEN1-related tumors were documented and the prevalence of prolactinoma (29.6%) was similar to that previously described in prolactinoma-variant Burin (32%). In addition, bone mineral density analysis revealed severe osteoporosis (T, -2.87+/-0.32) of compact bone (distal radius) in hyperparathyroidism (HPT)/MEN1 patients, while marked bone mineral loss in the lumbar spine (T, -1.95+/-0.39), with most cancellous bone, and femoral neck (mixed composition; T, -1.48+/-0.27) were also present.
CONCLUSIONS: In this study, we described clinically and genetically the fifth largest MEN1 family in the literature. Our data confirm previous findings suggesting that prevalence of MEN1-related tumors in large families may differ from reports combining cumulative data of small families. Furthermore, we were able to evaluate the bone status in HPT/MEN1 cases, a subject that has been incompletely approached in the literature. We discussed the bone loss pattern found in our MEN1 patients comparing with that of patients with sporadic primary HPT.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18524795     DOI: 10.1530/EJE-08-0153

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  28 in total

1.  Parathyroid gland: Hyperparathyroidism in MEN1 syndrome: time to operate?

Authors:  Maria Luisa Brandi
Journal:  Nat Rev Endocrinol       Date:  2010-11       Impact factor: 43.330

Review 2.  Multiple endocrine neoplasia type 1 revealed by a hip pathologic fracture.

Authors:  Maroua Slouma; Maissa Abbes; Rim Dhahri; Noureddine Litaiem; Nour Gueddiche; Nada Mansouri; Issam Msekni; Imen Gharsallah; Leila Metoui; Bassem Louzir
Journal:  Clin Rheumatol       Date:  2020-07-14       Impact factor: 2.980

3.  Impaired geometry, volumetric density, and microstructure of cortical and trabecular bone assessed by HR-pQCT in both sporadic and MEN1-related primary hyperparathyroidism.

Authors:  W Wang; M Nie; Y Jiang; M Li; X Meng; X Xing; O Wang; W Xia
Journal:  Osteoporos Int       Date:  2019-10-23       Impact factor: 4.507

4.  Peripheral bone mineral density in correlation to disease-related predisposing conditions in patients with multiple endocrine neoplasia type 1.

Authors:  P H Kann; D Bartsch; P Langer; J Waldmann; P Hadji; A Pfützner; J Klüsener
Journal:  J Endocrinol Invest       Date:  2011-07-27       Impact factor: 4.256

5.  Isolated familial somatotropinoma: 11q13-loh and gene/protein expression analysis suggests a possible involvement of aip also in non-pituitary tumorigenesis.

Authors:  Rodrigo A Toledo; Berenice B Mendonca; Maria Candida B V Fragoso; Iberê C Soares; Madson Q Almeida; Michelle B Moraes; Delmar M Lourenço; Venâncio A F Alves; Marcello D Bronstein; Sergio P A Toledo
Journal:  Clinics (Sao Paulo)       Date:  2010-04       Impact factor: 2.365

6.  Frequency of multiple endocrine neoplasia type 1 in a group of patients with pituitary adenoma: genetic study and familial screening.

Authors:  V S Nunes; G L Souza; D Perone; S J Conde; C R Nogueira
Journal:  Pituitary       Date:  2014-02       Impact factor: 4.107

7.  Reverse referral: from pathology to endocrinology.

Authors:  Selma Feldman Witchel; Sarangarajan Ranganathan; Megan Kilpatrick; Sally E Carty
Journal:  Endocr Pathol       Date:  2009       Impact factor: 3.943

Review 8.  The future: genetics advances in MEN1 therapeutic approaches and management strategies.

Authors:  Sunita K Agarwal
Journal:  Endocr Relat Cancer       Date:  2017-10       Impact factor: 5.678

9.  A large Turkish pedigree with multiple endocrine neoplasia type 1 syndrome carrying a rare mutation: c.1680_1683 del TGAG.

Authors:  Coşkun Özer Demirtaş; Pınar Ata; Ali Çetin; Ayberk Türkyılmaz; Deniz Guney Duman
Journal:  Turk J Gastroenterol       Date:  2020-07       Impact factor: 1.852

Review 10.  Hypercalcitoninemia is not pathognomonic of medullary thyroid carcinoma.

Authors:  Sergio P A Toledo; Delmar M Lourenço; Marcelo Augusto Santos; Marcos R Tavares; Rodrigo A Toledo; Joya Emilie de Menezes Correia-Deur
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.